Figure 3.
Figure 3. Competitive repopulation assay of LT-HSCs. (A) Experimental procedure and incidence of CMML. LT-HSCs or ST-HSCs and MPPs from control or CblQ367P mice (Ly5.2+) were transplanted into irradiated syngeneic mice (Ly5.1+) with competitor BM mononuclear cells (Ly5.1+), and Ly5.2+ cells in the recipient mice were analyzed. The incidence of CMML in the recipient mice is shown. (B) Changes of total and lineage marker–positive Ly5.2+ cells in the PB during the observation period. (C) Numbers of lineage marker–positive Ly5.2+ cells in the PB and the spleen and macroscopic appearances of the spleens in recipient mice at the endpoint of transplantation. ***P < .001; **P < .01, *P < .05. ns, not significant.

Competitive repopulation assay of LT-HSCs. (A) Experimental procedure and incidence of CMML. LT-HSCs or ST-HSCs and MPPs from control or CblQ367P mice (Ly5.2+) were transplanted into irradiated syngeneic mice (Ly5.1+) with competitor BM mononuclear cells (Ly5.1+), and Ly5.2+ cells in the recipient mice were analyzed. The incidence of CMML in the recipient mice is shown. (B) Changes of total and lineage marker–positive Ly5.2+ cells in the PB during the observation period. (C) Numbers of lineage marker–positive Ly5.2+ cells in the PB and the spleen and macroscopic appearances of the spleens in recipient mice at the endpoint of transplantation. ***P < .001; **P < .01, *P < .05. ns, not significant.

Close Modal

or Create an Account

Close Modal
Close Modal